Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer
Abstract Background Indocyanine green (ICG) is becoming a frequently used sentinel lymph node (SLN) tracer of breast cancer in China. However, there is still a lack of data on its safety. We reported the clinical outcome of ICG as a tracer of SLN over a median 67-month follow-up period to evaluate i...
Main Authors: | Bin Hua, Yao Li, Xin Yang, Xiaotian Ren, Xu Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02719-7 |
Similar Items
-
The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study
by: Migle Gedgaudaite, et al.
Published: (2022-05-01) -
Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer
by: Joseph Lin, et al.
Published: (2020-12-01) -
A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer
by: Yoshikazu Masai, et al.
Published: (2010-04-01) -
Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green
by: Aoyama Kei, et al.
Published: (2011-12-01) -
A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer
by: Michel Coibion, et al.
Published: (2022-02-01)